Exact Mass: 505.2013

Exact Mass Matches: 505.2013

Found 30 metabolites which its exact mass value is equals to given mass value 505.2013, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Asp Asp Glu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-4-carboxybutanamido]hexanoic acid

C19H31N5O11 (505.202)


   

Asp Asp Lys Glu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]hexanamido]pentanedioic acid

C19H31N5O11 (505.202)


   

Asp Glu Asp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carboxybutanamido]-3-carboxypropanamido]hexanoic acid

C19H31N5O11 (505.202)


   

Asp Glu Lys Asp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carboxybutanamido]hexanamido]butanedioic acid

C19H31N5O11 (505.202)


   

Asp Lys Asp Glu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carboxypropanamido]hexanamido]-3-carboxypropanamido]pentanedioic acid

C19H31N5O11 (505.202)


   

Asp Lys Glu Asp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carboxypropanamido]hexanamido]-4-carboxybutanamido]butanedioic acid

C19H31N5O11 (505.202)


   

Glu Asp Asp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carboxypropanamido]-3-carboxypropanamido]hexanoic acid

C19H31N5O11 (505.202)


   

Glu Asp Lys Asp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carboxypropanamido]hexanamido]butanedioic acid

C19H31N5O11 (505.202)


   

Glu Glu Gln Thr

(4S)-4-[(2S)-2-amino-4-carboxybutanamido]-4-{[(1S)-3-carbamoyl-1-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}propyl]carbamoyl}butanoic acid

C19H31N5O11 (505.202)


   

Glu Glu Thr Gln

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-carboxybutanamido]-3-hydroxybutanamido]-4-carbamoylbutanoic acid

C19H31N5O11 (505.202)


   

Glu Lys Asp Asp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carboxybutanamido]hexanamido]-3-carboxypropanamido]butanedioic acid

C19H31N5O11 (505.202)


   

Glu Gln Glu Thr

(4S)-4-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-carbamoylbutanamido]-4-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}butanoic acid

C19H31N5O11 (505.202)


   

Glu Gln Thr Glu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-carbamoylbutanamido]-3-hydroxybutanamido]pentanedioic acid

C19H31N5O11 (505.202)


   

Glu Thr Glu Gln

(4S)-4-[(2S,3R)-2-[(2S)-2-amino-4-carboxybutanamido]-3-hydroxybutanamido]-4-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}butanoic acid

C19H31N5O11 (505.202)


   

Glu Thr Gln Glu

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-carboxybutanamido]-3-hydroxybutanamido]-4-carbamoylbutanamido]pentanedioic acid

C19H31N5O11 (505.202)


   

Lys Asp Asp Glu

(2S)-2-[(2S)-3-carboxy-2-[(2S)-3-carboxy-2-[(2S)-2,6-diaminohexanamido]propanamido]propanamido]pentanedioic acid

C19H31N5O11 (505.202)


   

Lys Asp Glu Asp

(2S)-2-[(2S)-4-carboxy-2-[(2S)-3-carboxy-2-[(2S)-2,6-diaminohexanamido]propanamido]butanamido]butanedioic acid

C19H31N5O11 (505.202)


   

Lys Glu Asp Asp

(2S)-2-[(2S)-3-carboxy-2-[(2S)-4-carboxy-2-[(2S)-2,6-diaminohexanamido]butanamido]propanamido]butanedioic acid

C19H31N5O11 (505.202)


   

Gln Glu Glu Thr

(4S)-4-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-carboxybutanamido]-4-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}butanoic acid

C19H31N5O11 (505.202)


   

Gln Glu Thr Glu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-carboxybutanamido]-3-hydroxybutanamido]pentanedioic acid

C19H31N5O11 (505.202)


   

Gln Thr Glu Glu

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxybutanamido]-4-carboxybutanamido]pentanedioic acid

C19H31N5O11 (505.202)


   

Thr Glu Glu Gln

(4S)-4-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-{[(1S)-1-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}-3-carboxypropyl]carbamoyl}butanoic acid

C19H31N5O11 (505.202)


   

Thr Glu Gln Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carboxybutanamido]-4-carbamoylbutanamido]pentanedioic acid

C19H31N5O11 (505.202)


   

Thr Gln Glu Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carbamoylbutanamido]-4-carboxybutanamido]pentanedioic acid

C19H31N5O11 (505.202)


   

Nefazodone hydrochloride

Nefazodone hydrochloride

C25H33Cl2N5O2 (505.2011)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D000068760 - Serotonin and Noradrenaline Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators Nefazodone hydrochloride (BMY-13754) is a potent and selective 5HT2A (Ki=5.8 nM) antagonist with moderate inhibition of 5-HT and noradrenaline uptake (IC50 of 290 and 300 nM, respectively). Nefazodone hydrochloride is a phenylpiperazine antidepressant with less alpha-adrenergic blocking activity[1][2].

   

2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide

2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide

C28H28FN3O5 (505.2013)


   

2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-pyridin-4-ylacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide

2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-pyridin-4-ylacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide

C28H28FN3O5 (505.2013)


   

2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-pyridin-4-ylacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide

2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-pyridin-4-ylacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide

C28H28FN3O5 (505.2013)


   

2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide

2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide

C28H28FN3O5 (505.2013)


   

2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide

2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide

C28H28FN3O5 (505.2013)